209 related articles for article (PubMed ID: 33509178)
1. Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.
Song Y; Yang K; Sun T; Tang R
BMC Med Genomics; 2021 Jan; 14(1):31. PubMed ID: 33509178
[TBL] [Abstract][Full Text] [Related]
2. Multi-omics analysis at epigenomics and transcriptomics levels reveals prognostic subtypes of lung squamous cell carcinoma.
Xu Y; She Y; Li Y; Li H; Jia Z; Jiang G; Liang L; Duan L
Biomed Pharmacother; 2020 May; 125():109859. PubMed ID: 32036209
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of genomic, epigenomic and transcriptomic data identified molecular subtypes of esophageal carcinoma.
Ma M; Chen Y; Chong X; Jiang F; Gao J; Shen L; Zhang C
Aging (Albany NY); 2021 Feb; 13(5):6999-7019. PubMed ID: 33638948
[TBL] [Abstract][Full Text] [Related]
4. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
Zhao Y; Gao Y; Xu X; Zhou J; Wang H
BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346
[TBL] [Abstract][Full Text] [Related]
5. Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinoma.
Zheng M; Hu Y; Gou R; Wang J; Nie X; Li X; Liu Q; Liu J; Lin B
Aging (Albany NY); 2019 Jun; 11(12):4198-4215. PubMed ID: 31257224
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis of genomic and epigenetic regulation of endometrial cancer.
Zhong Q; Fan J; Chu H; Pang M; Li J; Fan Y; Liu P; Wu C; Qiao J; Li R; Hang J
Aging (Albany NY); 2020 May; 12(10):9260-9274. PubMed ID: 32412912
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive data analysis of genomics, epigenomics, and transcriptomics to identify specific biomolecular markers for prostate adenocarcinoma.
Ye C; Wang H; Li Z; Xia C; Yuan S; Yan R; Yang X; Ma T; Wen X; Yang D
Transl Androl Urol; 2021 Jul; 10(7):3030-3045. PubMed ID: 34430406
[TBL] [Abstract][Full Text] [Related]
8. Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer.
Kong L; Liu P; Zheng M; Xue B; Liang K; Tan X
Epigenomics; 2020 Mar; 12(6):507-524. PubMed ID: 32048534
[No Abstract] [Full Text] [Related]
9. Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma.
Chen W; Cheng P; Jiang J; Ren Y; Wu D; Xue D
Aging (Albany NY); 2020 Jul; 12(13):12703-12725. PubMed ID: 32639949
[TBL] [Abstract][Full Text] [Related]
10. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
11. Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma.
Huang Z; Li B; Guo Y; Wu L; Kou F; Yang L
Front Immunol; 2021; 12():723172. PubMed ID: 34539658
[TBL] [Abstract][Full Text] [Related]
12. Integrated Analysis of Multiomics Data Identified Molecular Subtypes and Oxidative Stress-Related Prognostic Biomarkers in Glioblastoma Multiforme.
Ma Y; Xi Z
Oxid Med Cell Longev; 2022; 2022():9993319. PubMed ID: 36193073
[TBL] [Abstract][Full Text] [Related]
13. Multi-Omics Integrative Analysis Uncovers Molecular Subtypes and mRNAs as Therapeutic Targets for Liver Cancer.
Shen Y; Xiong W; Gu Q; Zhang Q; Yue J; Liu C; Wang D
Front Med (Lausanne); 2021; 8():654635. PubMed ID: 34109194
[No Abstract] [Full Text] [Related]
14. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data.
Zhong Q; Lu M; Yuan W; Cui Y; Ouyang H; Fan Y; Wang Z; Wu C; Qiao J; Hang J
J Transl Med; 2021 Feb; 19(1):58. PubMed ID: 33557879
[TBL] [Abstract][Full Text] [Related]
15. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
Mo W; Ding Y; Zhao S; Zou D; Ding X
PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
[TBL] [Abstract][Full Text] [Related]
16. Multi-omics analysis of copy number variations of RNA regulatory genes in soft tissue sarcoma.
Wang X; Han Y; Li J; Hong D; Xue Z; Huang H; Du Z; Hou Y; Li H; Li H; Liao H; Xie X; Ding C
Life Sci; 2021 Jan; 265():118734. PubMed ID: 33166590
[TBL] [Abstract][Full Text] [Related]
17. Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
Zheng M; Hu Y; Gou R; Nie X; Li X; Liu J; Lin B
Biomed Pharmacother; 2020 Apr; 124():109810. PubMed ID: 32000042
[TBL] [Abstract][Full Text] [Related]
18. Identification of 5 Gene Signatures in Survival Prediction for Patients with Lung Squamous Cell Carcinoma Based on Integrated Multiomics Data Analysis.
Ma H; Tong L; Zhang Q; Chang W; Li F
Biomed Res Int; 2020; 2020():6427483. PubMed ID: 32596344
[TBL] [Abstract][Full Text] [Related]
19. Can DNA Methylation Profiling Classify Histologic Subtypes and Grades in Soft Tissue Sarcoma?
Kim H; Joo MW; Yoon J; Park HS; Kim JH; Lee JH; Kim SH; Lee SK; Chung YG; Cho YJ
Clin Orthop Relat Res; 2024 Mar; ():. PubMed ID: 38517415
[TBL] [Abstract][Full Text] [Related]
20. Identification of seven-gene marker to predict the survival of patients with lung adenocarcinoma using integrated multi-omics data analysis.
Zhang S; Zeng X; Lin S; Liang M; Huang H
J Clin Lab Anal; 2022 Feb; 36(2):e24190. PubMed ID: 34951053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]